Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Authors not listed

Cliniques universitaires Saint-Luc- Université Catholique de Louvain · 2026

Abstract

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Anonymous. (2026). Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases. <em>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</em>. https://clinicaltrials.gov/study/NCT07703683
Vancouver
Anonymous. Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases. Cliniques universitaires Saint-Luc- Université Catholique de Louvain. 2026.
BibTeX
@misc{anon2026Myokin, title = {Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases}, author = {Anonymous}, journal = {Cliniques universitaires Saint-Luc- Université Catholique de Louvain}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings